NovaBridge Biosciences (NBP) Shares Outstanding (Diluted Average) (2017 - 2025)

NovaBridge Biosciences (NBP) has 9 years of Shares Outstanding (Diluted Average) data on file, last reported at $220.3 million in Q4 2025.

• Shares Outstanding (Diluted Average) for Q4 2025 came in at $220.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $220.3 million (changed N/A YoY), and the FY2025 annual result was $220.3 million, changed N/A from the prior year.
• Shares Outstanding (Diluted Average) improved to $220.3 million in Q4 2025 per NBP's latest filing, from $170.0 in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $220.3 million in Q4 2025 and troughed at $110.0 in Q2 2024.
• A 5-year average of $58.2 million and a median of $26.7 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
• The sharpest annual moves came in 2021 and 2024: Shares Outstanding (Diluted Average) surged 6036364.12% in 2021, then slumped 100.0% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $27.3 million in 2021, then slipped by 2.35% to $26.7 million in 2022, then retreated by 0.37% to $26.6 million in 2023, then sank by 100.0% to $140.0 in 2024, then jumped by 157327708.57% to $220.3 million in 2025.
• Business Quant data shows NBP's Shares Outstanding (Diluted Average) at $220.3 million in Q4 2025, $170.0 in Q3 2025, and $110.0 in Q2 2025.